Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage

被引:100
作者
Feofanov, AV [1 ]
Sharonov, GV [1 ]
Astapova, MV [1 ]
Rodionov, DI [1 ]
Utkin, YN [1 ]
Arseniev, AS [1 ]
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
关键词
cobra venom; cytotoxicity; cytotoxin; lysosome; confocal spectral imaging;
D O I
10.1042/BJ20041892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Cytotoxins from cobra venom are known to manifest cytotoxicity in various cell types. It is widely accepted that the plasma membrane is a target of cytotoxins, but the mechanism of their action remains obscure. Using the confocal spectral imaging technique, we show for the first time that cytotoxins from cobra venom penetrate readily into living cancer cells and accumulate markedly in lysosomes. Cytotoxins CT1 and CT2 from Naja oxiana, CT3 from Naja kaouthia and CT1 from Naja haje are demonstrated to possess this property with respect to human lung adenocarcinoma A549 and promyelocytic leukaemia HL60 cells. Immobilized plasma membrane binding accompanies the internalization of CT3 from Naja kaouthia in the HL60 cells, but it is very weak for other cytotoxins. Detectable membrane binding is not a property of any of the cytotoxins tested in A549 cells. The kinetics and concentration-dependence of cytotoxin accumulation in lysosomes correlate well with their cytotoxic effects. On the basis of the results obtained, we propose that lysosomes are a primary target of the lytic action of cytotoxins. Plasma membrane permeabilization seems to be a downstream event relative to lysosome rupture. Direct damage to the plasma membrane may be a complementary mechanism, but its relative contribution to the cytotoxic action depends on the cytotoxin structure and cell type.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 40 条
[1]
X-RAY STRUCTURE AT 1-CENTER-DOT-55 ANGSTROM OF TOXIN-GAMMA, A CARDIOTOXIN FROM NAJA-NIGRICOLLIS VENOM - CRYSTAL PACKING REVEALS A MODEL FOR INSERTION INTO MEMBRANES [J].
BILWES, A ;
REES, B ;
MORAS, D ;
MENEZ, R ;
MENEZ, A .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 239 (01) :122-136
[2]
BORKOW G, 1992, FEMS MICROBIOL IMMUN, V105, P139
[3]
CHAIMMATYAS A, 1991, BIOCHEM INT, V24, P415
[4]
CHEN YH, 1984, BIOCHEM INT, V8, P329
[5]
Change and inactivation of membrane phospholipid-related activity of cardiotoxin V from Taiwan cobra venom at acidic pH [J].
Chiang, CM ;
Chien, KY ;
Lin, JH ;
Lin, JF ;
Yeh, HC ;
Ho, PL ;
Wu, WG .
BIOCHEMISTRY, 1996, 35 (28) :9167-9176
[6]
CHIEN KY, 1994, J BIOL CHEM, V269, P14473
[7]
COBRA VENOM CARDIOTOXIN (CYTOTOXIN) ISOFORMS AND NEUROTOXIN - COMPARATIVE POTENCY OF PROTEIN-KINASE-C INHIBITION AND CANCER CELL CYTOTOXICITY AND MODES OF ENZYME-INHIBITION [J].
CHIOU, SH ;
RAYNOR, RL ;
ZHENG, B ;
CHAMBERS, TC ;
KUO, JF .
BIOCHEMISTRY, 1993, 32 (08) :2062-2067
[8]
CHIOU SH, 1995, BIOCHEM MOL BIOL INT, V35, P1103
[9]
Interaction of the P-type cardiotoxin with phospholipid membranes [J].
Dubovskii, PV ;
Lesovoy, DM ;
Dubinnyi, MA ;
Utkin, YN ;
Arseniev, AS .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (09) :2038-2046
[10]
DUFON MJ, 1988, PHARMACOL THERAPEUT, V36, P1